104 related articles for article (PubMed ID: 3223828)
21. [Gastrointestinal features in systemic sclerosis].
Stelle M; Chizzolini C
Rev Med Suisse; 2014 Apr; 10(426):860-3. PubMed ID: 24834644
[TBL] [Abstract][Full Text] [Related]
22. [Changes in upper gastrointestinal motility during scleroderma].
Bassotti G; Betti C; Pelli MA; Morelli A
Medicina (Firenze); 1990; 10(3):251-5. PubMed ID: 2079874
[TBL] [Abstract][Full Text] [Related]
23. Gastrointestinal manifestations of scleroderma.
Rose S; Young MA; Reynolds JC
Gastroenterol Clin North Am; 1998 Sep; 27(3):563-94. PubMed ID: 9891698
[TBL] [Abstract][Full Text] [Related]
24. Nutrition in systemic sclerosis.
Recasens MA; Puig C; Ortiz-Santamaria V
Reumatol Clin; 2012; 8(3):135-40. PubMed ID: 22197834
[TBL] [Abstract][Full Text] [Related]
25. Systemic Sclerosis: Gastrointestinal Disease and Its Management.
Gyger G; Baron M
Rheum Dis Clin North Am; 2015 Aug; 41(3):459-73. PubMed ID: 26210129
[TBL] [Abstract][Full Text] [Related]
26. Esophageal function in progressive systemic sclerosis.
Krejs GJ; Lobsiger MM; Rau R; Bron BA; von Büren US; Peter P; Brändli HH; Pirozynski W; Blum AL
Acta Hepatogastroenterol (Stuttg); 1976 Feb; 23(1):40-6. PubMed ID: 1258601
[TBL] [Abstract][Full Text] [Related]
27. Esophageal dysfunction in patients with progressive systemic sclerosis and mixed connective tissue diseases.
Dantas RO; Villanova MG; de Godoy RA
Arq Gastroenterol; 1985; 22(3):122-6. PubMed ID: 3836619
[TBL] [Abstract][Full Text] [Related]
28. Association of gastroesophageal factors and worsening of forced vital capacity in systemic sclerosis.
Zhang XJ; Bonner A; Hudson M; ; Baron M; Pope J
J Rheumatol; 2013 Jun; 40(6):850-8. PubMed ID: 23547215
[TBL] [Abstract][Full Text] [Related]
29. Small intestinal bacterial overgrowth in the symptomatic elderly.
Riordan SM; McIver CJ; Wakefield D; Bolin TD; Duncombe VM; Thomas MC
Am J Gastroenterol; 1997 Jan; 92(1):47-51. PubMed ID: 8995936
[TBL] [Abstract][Full Text] [Related]
30. Diffuse Gastrointestinal Motor Compromise in Patients with Scleroderma: Utility of Minimally Invasive Techniques.
von Mühlenbrock C; Madrid AM; Defilippi C; Defilippi C; Soto L
Dig Dis Sci; 2024 Jan; 69(1):191-199. PubMed ID: 37982941
[TBL] [Abstract][Full Text] [Related]
31. Esophageal involvement and pulmonary manifestations in systemic sclerosis.
Marie I; Dominique S; Levesque H; Ducrotté P; Denis P; Hellot MF; Courtois H
Arthritis Rheum; 2001 Aug; 45(4):346-54. PubMed ID: 11501722
[TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal manifestations in Hungarian scleroderma patients.
Szamosi S; Szekanecz Z; Szucs G
Rheumatol Int; 2006 Oct; 26(12):1120-4. PubMed ID: 16770615
[TBL] [Abstract][Full Text] [Related]
33. [Gastrointestinal involvement in progressive systemic scleroderma].
Folwaczny C; Rothfuss U; Riepl RL; Lehnert P; Bloching H; Meurer M; Karbach U
Z Gastroenterol; 1995 Nov; 33(11):654-61. PubMed ID: 8600662
[TBL] [Abstract][Full Text] [Related]
34. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
35. Gastrointestinal manifestations of systemic sclerosis.
Domsic R; Fasanella K; Bielefeldt K
Dig Dis Sci; 2008 May; 53(5):1163-74. PubMed ID: 17934861
[TBL] [Abstract][Full Text] [Related]
36. [Digestive disorders in systemic scleroderma].
Marie I
Rev Med Interne; 2002 May; 23 Suppl 1():19s-20s. PubMed ID: 12108187
[No Abstract] [Full Text] [Related]
37. [Scintigraphic diagnosis of esophageal involvement in systemic sclerosis (scleroderma)].
von Mühlen CA; Anselmi OE; Ludwig EB; Cutin J
Z Rheumatol; 1989; 48(4):167-74. PubMed ID: 2508356
[TBL] [Abstract][Full Text] [Related]
38. The pattern of esophageal manometry in progressive systemic sclerosis.
Al-Amri SM
Saudi Med J; 2003 Jan; 24(1):68-71. PubMed ID: 12590279
[TBL] [Abstract][Full Text] [Related]
39. Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients.
Yarze JC; Varga J; Stampfl D; Castell DO; Jimenez SA
Am J Gastroenterol; 1993 Jun; 88(6):870-6. PubMed ID: 8503383
[TBL] [Abstract][Full Text] [Related]
40. Small intestinal bacterial overgrowth in systemic sclerosis.
Marie I; Ducrotté P; Denis P; Menard JF; Levesque H
Rheumatology (Oxford); 2009 Oct; 48(10):1314-9. PubMed ID: 19696066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
